Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (KCT0012641) titled 'A Study of Adjusting Radiation Treatment Using Biomarkers in Patients with Oropharyngeal Cancer' on Sept. 17.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Single Group, Blinding/Masking : Open, Allocation : Non-RCT
Primary Sponsor: National Cancer Center
Condition:
Neoplasms
Intervention:
Radiation : Patients are stratified according to their risk based on changes in blood HPV16 ctDNA during treatment, and the radiation dose is adjusted according to the risk group. All participants receive an initial radiation dose of 44 Gy over 4 weeks, followed by additiona...